Renaissance Capital logo

LICN News

US IPO Weekly Recap: February IPO market warms up with 4 large deals

NXT

Six IPOs began trading this past week, led by four that raised $100+ million, the most in one week since November 2021. They were joined by two SPACs. Several small deals were unable to price (SODR, INTS, BFRG, NFTG, CWD, NRXS). Upsizing and pricing above the range, Nextracker (NXT) raised $638 million at a $3.5 billion market cap in the year’s...read more

Micro-cap financial and tax services provider Lichen China prices downsized US IPO at $4

LICN

Lichen China, which provides financial and tax services in China, raised $16 million by offering 4.0 million shares at $4. The company had planned to sell 4.5 million shares at that price, but lowered its deal size by 11% at the offering. Lichen China listed on the Nasdaq on Monday under the symbol LICN. Univest Securities acted as sole bookrunner on the deal....read more

Financial services provider Lichen China lowers proposed share offering by 28% ahead of $18 million US IPO

LICN

Lichen China, which provides financial and tax consultation and education support services in China, lowered the proposed deal size for its upcoming IPO on Thursday. The Jinjiang, China-based company now plans to raise $18 million by offering 4.5 million shares at $4. The company had previously filed to offer 6.3 million shares at the same price. At the revised terms, Lichen China...read more

US IPO Week Ahead: Corebridge plots the year’s largest IPO

CRBG

Six deals are expected to begin trading in the week ahead, though only five meet the criteria for our IPO stats. The group is led by AIG carve-out Corebridge Financial (CRBG) and biotech Third Harmonic Bio (THRD). In what could be the largest deal of 2022 so far, Corebridge plans to raise $1.8 billion at a fully diluted market...read more